These final results, together with a prior report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 guidance the concept of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Ailments.So, right before investing in this n